510(k) Report

510(k) · Cleared

Cleared

Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral Dilatation Catheters; Passeo-14 Peripheral Dilatation Catheter; Oscar Peripheral Multifunctional Catheter System; Pantera Pro Percutaneous Transluminal Coronary Angioplasty Catheter; Pantera LEO Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter

K250706510(k) SpecialCleared Apr 4, 202525-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biotronik, Inc. · LIT Catheter, Angioplasty, Peripheral, Transluminal

Cleared on Apr 4, 2025 as substantially equivalent to K222065 (Biotronik, Inc., 2023) and 4 other predicates after a 25-day review. Its family tree reaches back 9 generations to 2000.

Decided
Apr 4, 2025
Review
25 days
Class
Class II
Product code
LIT
Recalls
None
Predicates
5

Its longest line of descent runs back 9 generations to K001134 (2000). 27 ancestors in all, the oldest P790017 (1980). No later device cites it as a predicate yet.

  1. Root · 9 generations backK001134 Gazelle Balloon Dilatation CatheterBoston Scientific Corp · 2000
  2. 5 generations between
  3. 3 generations backK192399 Infinity Angioplasty Balloon CatheterInfinity Angioplasty Balloon Company, LLC · 2020
  4. 2 generations backK214038 Oscar Peripheral Multifunctional Catheter systemBiotronik, Inc. · 2022
  5. 1 generation backK241711 Oscar Peripheral Multifunctional Catheter systemBiotronik, Inc. · 2024
  6. This deviceK250706 Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral…Biotronik, Inc. · 2025
Show all 9 generations
  1. Root · 9 generations backK001134 Gazelle Balloon Dilatation CatheterBoston Scientific Corp · 2000
  2. 8 generations backK021735 Boston Scientific Ultra-Soft SV Balloon Dilatation CatheterBoston Scientific Scimed, Inc. · 2002 · Recalled
  3. 7 generations backK050389 Ultra-Soft SV Balloon Dilatation CatheterBoston Scientific Corp · 2005
  4. 6 generations backK053116 Sterling Otw Pta Balloon Dilatation Catheter, Model H74939032-XxxxxxBoston Scientific Corp · 2005
  5. 5 generations backK132430 Sterling Over-the-Wire (Otw) Pta Balloon Dilatation CatheterBoston Scientific Corp · 2013
  6. 4 generations backK141112 Sterling Over-the Wire Pta Balloon Dilatation CatheterBoston Scientific · 2014
  7. 3 generations backK192399 Infinity Angioplasty Balloon CatheterInfinity Angioplasty Balloon Company, LLC · 2020
  8. 2 generations backK214038 Oscar Peripheral Multifunctional Catheter systemBiotronik, Inc. · 2022
  9. 1 generation backK241711 Oscar Peripheral Multifunctional Catheter systemBiotronik, Inc. · 2024
  10. This deviceK250706 Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral…Biotronik, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K001134Gazelle Balloon Dilatation CatheterBoston Scientific Corp2000—
−8K021735Boston Scientific Ultra-Soft SV Balloon Dilatation CatheterBoston Scientific Scimed, Inc.200223
−7K050389Ultra-Soft SV Balloon Dilatation CatheterBoston Scientific Corp2005—
−6K053116Sterling Otw Pta Balloon Dilatation Catheter, Model H74939032-XxxxxxBoston Scientific Corp2005—
−5K132430Sterling Over-the-Wire (Otw) Pta Balloon Dilatation CatheterBoston Scientific Corp2013—
−4K141112Sterling Over-the Wire Pta Balloon Dilatation CatheterBoston Scientific2014—
−3K192399Infinity Angioplasty Balloon CatheterInfinity Angioplasty Balloon Company, LLC2020—
−2K214038Oscar Peripheral Multifunctional Catheter systemBiotronik, Inc.2022—
−1K241711Oscar Peripheral Multifunctional Catheter systemBiotronik, Inc.2024—
0 (this device)K250706Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral Dilatation…Biotronik, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198010
198610
200010
200120
200210
200310
200510
200710
200810
201010
201410
201520
201610
201710
202310
202410
FIG. 1 — Lineage of K250706, 2000–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIT device

  1. #1 K241040 Amethyst HP PTA OTW 0.035 Catheterscore 13.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K222065Passeo-35 Xeo Peripheral Dilatation Catheter
Summary page 10
…Type: Catheter, angioplasty, peripheral, transluminal Product Code: LIT Regulation Number 870.1250 Predicate Device: Passeo-35 Xeo (K222065) Device Description BIOTRONIK’s Passeo 35 Xeo Catheter is an over-the-wire (OTW) balloon dilatation catheter, indicated for di…
Biotronik, Inc.2023—
*K151744Passeo-18 Peripheral Dilation Catheter
Summary page 15
…Type: Catheter, angioplasty, peripheral, transluminal Product Code: LIT Regulation Number 870.1250 Predicate Device: Passeo-18 (K151744) Device Description The Passeo-18 peripheral dilatation catheter is intended for dilatation of stenotic segments in peripheral…
Biotronik, Inc.2015—
*K152240Passeo-14 Peripheral Dilatation Catheter
Summary page 21
…Type: Catheter, angioplasty, peripheral, transluminal Product Code: LIT Regulation Numbers 870.1250 Predicate Device: Passeo-14 (K152240) Device Description The Passeo-14 peripheral dilatation catheter is intended for the dilatation of stenotic segments in lower…
Biotronik, Inc.2015—
*K241711Oscar Peripheral Multifunctional Catheter system
Summary page 26
…gioplasty, peripheral, transluminal Product Code: LIT (Primary), KRA (Secondary) Regulation Number 870.1250, 870.1210 Predicate Device: Oscar (K241711) Device Description The Oscar Peripheral Multifunctional Catheter system is an intravascular balloon catheter system, supplied…
Biotronik, Inc.2024—
*K242969Pantera Pro; Pantera LEO
Summary page 31
…Catheter, transluminal coronary angioplasty, percutaneous Product Code: LOX Regulation Number 870.5100 Predicate Device: Pantera LEO (K242969) Device Description Pantera LEO is a PTCA rapid exchange system with a balloon at the distal end of the catheter. A Luer port…
Biotronik, Inc.2024—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 5 companies; a new generation was cleared every 2.0 years on median.
  • 2 of the 27 ancestors have a recall of any class.

How does its category compare?

All LIT devices

LIT Catheter, Angioplasty, Peripheral, Transluminal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · LIT

3in 2025

2007: 62008: 82009: 72010: 132011: 102012: 192013: 142014: 122015: 192016: 112017: 92018: 62019: 42020: 92021: 42022: 82023: 62024: 62025: 32026 (partial year): 4
2007high 19 (2012) · low 3 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIT

90in 2025

2007: 64 days median2008: 53 days median2009: 29 days median2010: 78 days median2011: 82 days median2012: 29 days median2013: 79 days median2014: 90 days median2015: 112 days median2016: 116 days median2017: 57 days median2018: 118 days median2019: 40 days median2020: 125 days median2021: 61 days median2022: 122 days median2023: 167 days median2024: 43 days median2025: 90 days median2026 (partial year): 205 days median
2007high 205 (2026) · low 29 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIT

1in 2025

2009: 22010: 12013: 2, 2 Class I2014: 32016: 12018: 22019: 32021: 12024: 22025: 1
2007high 3 (2014) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · LIT

2,073in 2025

2007: 5772008: 5132009: 6232010: 8092011: 8572012: 1,2772013: 1,2422014: 1,1782015: 1,2792016: 1,5292017: 2,0812018: 2,1882019: 2,4052020: 2,4432021: 2,4922022: 2,1552023: 1,8072024: 1,9132025: 2,073
2007high 2,492 (2021) · low 513 (2008)2025

MAUDE reports naming product code LIT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076640577
20088530513
20097292623
201013781809
201110820857
2012192901,277
201314792 (2)1,242
2014129031,178
20151911201,279
20161111611,529
201795702,081
2018611822,188
201944032,405
2020912502,443
202146112,492
2022812202,155
2023616701,807
202464321,913
202539012,073
202642050—

What is it indicated for?

The Passeo-35 Xeo peripheral dilatation catheter is indicated to dilate stenosis in the iliac, femoral, popliteal and infrapopliteal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. Passeo-35 Xeo is also recommended for post-dilatation of balloon expandable and self-expanding stents in the peripheral vasculature. The Passeo-18 peripheral dilatation catheter is indicated to dilate stenosis in…

Read the full statement (230 words)

The Passeo-35 Xeo peripheral dilatation catheter is indicated to dilate stenosis in the iliac, femoral, popliteal and infrapopliteal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. Passeo-35 Xeo is also recommended for post-dilatation of balloon expandable and self-expanding stents in the peripheral vasculature.

The Passeo-18 peripheral dilatation catheter is indicated to dilate stenosis in the femoral, popliteal and infrapopliteal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

Passeo-14 1s indicated for balloon dilatation of the stenotic portion of a lower limb artery for the purpose of improving perfusion.

The Oscar Peripheral Multifunctional Catheter system is indicated for percutaneous transluminal interventions in the peripheral vasculature to provide support during access into and to dilate stenoses in femoral, popliteal and infrapopliteal arteries.

The product is also intended for injection of radiopaque contrast media for the purpose of angiography.

The Pantera LEO is indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion and for post dilatation of coronary stents.

The Pantera Pro is indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion. The Pantera Pro (balloon diameter 2.0 — 4.0 mm) is also indicated for post-delivery expansion of balloon expandable stents.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K250706: Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral Dilatation Catheters; Passeo-14 Peripheral Dilatation Catheter; Oscar Peripheral Multifunctional Catheter System; Pantera Pro Percutaneous Transluminal Coronary Angioplasty Catheter; Pantera LEO Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K250706

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026